Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

SV40: A human pathogen?

R L Garcea1

  • 1Section of Pediatric Hematology/Oncology/Bone Marrow Transplantation, Department of Pediatrics, University of Colorado School of Medicine, 4200 East Ninth Ave., Denver, CO 80262, USA. bob.garcea@uchsc.edu

Disease Markers
|January 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.

Oncogene·2001
Same author

Immunization with a pentameric L1 fusion protein protects against papillomavirus infection.

Journal of virology·2001
Same author

Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1.

Journal of molecular biology·2001
Same author

Detection of SV40 DNA sequences in human tissue.

Methods in molecular biology (Clifton, N.J.)·2001
Same author

Antiviral T-cell-independent type 2 antibody responses induced in vivo in the absence of T and NK cells.

Virology·2001
Same author

Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16.

Molecular cell·2000
Same journal

RETRACTION: Pyrrosia petiolosa Extract Ameliorates Ethylene Glycol-Induced Urolithiasis in Rats by Inhibiting Oxidative Stress and Inflammatory Response.

Disease markers·2026
Same journal

Correction to "Estrogen Protects against Renal Ischemia-Reperfusion Injury by Regulating Th17/Treg Cell Immune Balance".

Disease markers·2026
Same journal

RETRACTION: miR-127-5p Targets JAM3 to Regulate Ferroptosis, Proliferation, and Metastasis in Malignant Meningioma Cells.

Disease markers·2026
Same journal

RETRACTION: Thyroxine Alleviates Energy Failure, Prevents Myocardial Cell Apoptosis, and Protects against Doxorubicin-Induced Cardiac Injury and Cardiac Dysfunction via the LKB1/AMPK/mTOR Axis in Mice.

Disease markers·2026
Same journal

RETRACTION: Kartogenin Induced Adipose-Derived Stem Cell Exosomes Enhance the Chondrogenic Differentiation Ability of Adipose-Derived Stem Cells.

Disease markers·2026
Same journal

Correction to "KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells".

Disease markers·2026
See all related articles

Researchers are finding Simian virus 40 (SV40) DNA in human samples, including cancers. Further studies are needed to confirm if SV40 is a human pathogen and explore potential immunizations.

Area of Science:

  • Virology
  • Oncology
  • Epidemiology

Background:

  • Simian virus 40 (SV40) DNA has been increasingly detected in human samples, both cancerous and normal, over the past eight years.
  • Specific tumor types, including choroid plexus neoplasms, ependymomas, osteosarcomas, and mesotheliomas, are recurrently reported as SV40-positive.
  • Despite growing evidence, skepticism persists regarding SV40's role as a human pathogen.

Purpose of the Study:

  • To address the ongoing debate surrounding SV40's presence in humans.
  • To renew interest in related human polyomaviruses, BK (BKV) and JC (JCV), and their disease associations.
  • To outline future research directions for clarifying SV40's role in human health and disease.

Main Methods:

  • Review of existing literature on SV40 detection in human samples.

Related Experiment Videos

  • Proposal for seroepidemiologic studies using specific reagents to differentiate immune responses to SV40, BKV, and JCV.
  • Recommendation for prospective studies with optimized detection methods in select patient groups.

    • Main Results:

    • SV40 genomic sequences have been found in various human samples, including malignant and normal tissues.
    • Recurrent detection of SV40 in specific tumors like osteosarcomas and mesotheliomas has been reported.
    • The study highlights the need for further investigation despite existing findings.

    Conclusions:

    • Further research, including seroepidemiologic and prospective studies, is crucial to validate SV40's role as a human pathogen.
    • Understanding SV40, BKV, and JCV prevalence and association with human diseases is essential.
    • Potential for preventing human polyomavirus infections and associated malignancies through immunization warrants investigation.